Doctor profile · Federal record

Dr. Brett Stanaland, MD

Allergy Physician (CMS: Allergy/Immunology) · Naples, FL

  • NPI 1508865924
  • Accepts Medicare
  • MIPS 75.0 / 100 · 2023
  • 37 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1000 Goodlette RD N, Suite 200
Naples, FL 341025474
(239) 434-6200
fax (239) 434-5741

Credentials & registration

NPPES · NUCC
NPI registered
July 2005 — 21 yrs on file
Profile last updated
December 15, 2022
Year of graduation
1989 — 37 yrs since
Specialty taxonomy
207KA0200X — NUCC code
State license (1)
Florida #ME0062874
Medicaid
FL #378659500

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1508865924. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
77,156
Distinct HCPCS
10
Medicare allowed
$1,804,851
HCPCS Description Services Patients Avg allowed
J2356 Injection, tezepelumab-ekko, 1 mg 19,950 16 $18
J2182 Injection, mepolizumab, 1 mg 14,100 19 $29
J2357 Injection, omalizumab, 5 mg 12,525 31 $38
95004 Test for allergy using allergenic extract 11,060 184 $4
95165 Professional service for preparation and provision of 1 or more antigens 5,772 229 $15
95024 Test for allergy using allergenic extract injected into skin 5,123 156 $8
95117 Professional service for multiple injections of allergen 2,836 251 $12
99213 Established patient office or other outpatient visit, 20-29 minutes 2,064 1,272 $92
95115 Professional service for single injection of allergen 968 93 $10
95044 Test for allergy using skin patch 702 22 $5

In context: peer comparison

Among 1 peers in Naples Allergy Physician, average services per provider: 3,857. This provider delivers 20× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$195,588
Transactions
201
Manufacturers
13
Payer (manufacturer) Industry Txns Amount
AstraZeneca Pharmaceuticals Lp 92 $110,065.97
GlaxoSmithKline, LLC. 68 $74,518.68
Incyte Corporation 13 $10,078.26
Adma BioManufacturing LLC 1 $150.00
Csl Behring 6 $145.48
Genentech USA, INC. 3 $132.19
Genzyme Corporation 4 $122.15
Amgen INC. 3 $84.81
Takeda Pharmaceuticals U.S.A., INC. 3 $72.96
Regeneron Healthcare Solutions, INC. 2 $71.16
Grifols USA, LLC 3 $64.45
Abbvie INC. 2 $48.45
BioCryst US Sales Co., LLC 1 $33.11

By nature of payment

Compensation for Services Other Than Consulting, Including Serving As Faculty or As A Speaker at A Venue Other Than A Continuing Education Program
$169,365
Travel and Lodging
$20,304
Food and Beverage
$5,918

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
4,198
Patients
1,812
Total drug cost
$669,100
Drug Type Claims Patients Total cost
Montelukast Sodium Generic 773 270 $12,660
Azelastine Hcl Generic 767 349 $41,748
Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) Brand 523 105 $436,367
Ipratropium Bromide Generic 348 142 $26,272
Albuterol Sulfate Hfa (Albuterol Sulfate) Brand 279 129 $7,861
Azithromycin Generic 263 171 $1,743
Pantoprazole Sodium Generic 205 77 $4,188
Fluticasone Propionate Generic 181 67 $4,749
Amoxicillin-Clavulanate Potass (Amoxicillin/Potassium Clav) Brand 163 114 $2,153
Levocetirizine Dihydrochloride Generic 143 45 $2,483

Frequently asked questions

Auto-generated from federal data
What is Dr. Brett Stanaland's medical specialty?
Dr. Brett Stanaland practices Allergy Physician in Naples, FL.
Where does Dr. Brett Stanaland practice?
Dr. Brett Stanaland practices at 1000 Goodlette RD N, Naples, FL 341025474. Office phone: 2394346200.
What is Dr. Brett Stanaland's NPI?
Dr. Brett Stanaland's National Provider Identifier (NPI) is 1508865924, issued by NPPES.
Does Dr. Brett Stanaland accept Medicare assignment?
Yes. Dr. Brett Stanaland accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Brett Stanaland commonly perform?
Top Medicare-reported procedures in 2023: Injection, tezepelumab-ekko, 1 mg (HCPCS J2356); Injection, mepolizumab, 1 mg (HCPCS J2182); Injection, omalizumab, 5 mg (HCPCS J2357). Source: CMS Medicare Physician & Other Practitioners file.